Exagen Inc. XGN
3.80 USD -0.10 (-2.56%)
Regular-session close
3.81 +0.01 +0.26%
After hours · Nov 19, 4:36 PM ET
3.79 Day range 4.16
2.59 52-week range 9.22
- YTD
- -37.50%
- 1 year
- -51.96%
XGN revenue history
Revenue is income from the company’s ordinary business activities.
66,575,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 66,575,000 | 10,934,000 | 19.65% |
| FY 2024 | 2024-12-31 | 55,641,000 | 3,093,000 | 5.89% |
| FY 2023 | 2023-12-31 | 52,548,000 | 6,985,000 | 15.33% |
| FY 2022 | 2022-12-31 | 45,563,000 | -2,736,000 | -5.66% |
| FY 2021 | 2021-12-31 | 48,299,000 | 6,324,000 | 15.07% |
| FY 2020 | 2020-12-31 | 41,975,000 | 1,588,000 | 3.93% |
| FY 2019 | 2019-12-31 | 40,387,000 | 7,947,000 | 24.50% |
| FY 2018 | 2018-12-31 | 32,440,000 | 5,633,000 | 21.01% |
| FY 2017 | 2017-12-31 | 26,807,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:11.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
